Cargando…

Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization

Aceclofenac (AC) is a nonsteroidal anti-inflammatory drug used in the treatment of chronic pain in conditions such as rheumatoid arthritis, with frequent administration during the day. The formulation of sustained release matrix pellets can provide a promising alternative dosage form that controls t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Mohamed Abbas, Alshora, Doaa Hasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624669/ https://www.ncbi.nlm.nih.gov/pubmed/34833333 http://dx.doi.org/10.3390/polym13224034

Ejemplares similares

Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of Pellets Prepared by Extrusion-Spheronization for Possible Colonic Delivery of 5-Amino Salicylic Acid
por: Akhgari, Abbas, et al.
Publicado: (2013)

Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization
por: Garekani, Hadi Afrasiabi, et al.
Publicado: (2017)

Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization
por: Akhgari, A., et al.
Publicado: (2011)

Optimization of Pellets Containing Solid Dispersion Prepared by Extrusion/Spheronization Using Central Composite Design and Desirability Function
por: Singh, Gurinder, et al.
Publicado: (2012)

Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization
por: Ibrahim, Mohamed A., et al.
Publicado: (2019)

Production of Ibuprofen Pellets Containing High Amount of Rate Retarding Eudragit RL Using PEG400 and Investigation of Their Physicomechanical Properties
por: Sadeghi, Fatemeh, et al.
Publicado: (2011)

Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets
por: Maboos, Madiha, et al.
Publicado: (2018)

Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent—Meclizine HCl
por: Qazi, Faaiza, et al.
Publicado: (2017)

Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine
por: Salatin, Sara, et al.
Publicado: (2020)

Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit(®) RL 100 Nanoparticles for Ocular Delivery
por: Khin, Soe Yadanar, et al.
Publicado: (2022)

Differential Susceptibility of Catheter Biomaterials to Biofilm-Associated Infections and Their Remedy by Drug-Encapsulated Eudragit RL100 Nanoparticles
por: Pandey, Vivek Kumar, et al.
Publicado: (2019)

Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes
por: Ofokansi, Kenneth Chibuzor, et al.
Publicado: (2013)

Polyvinyl Alcohol/Chitosan Single-Layered and Polyvinyl Alcohol/Chitosan/Eudragit RL100 Multi-layered Electrospun Nanofibers as an Ocular Matrix for the Controlled Release of Ofloxacin: an In Vitro and In Vivo Evaluation
por: Mirzaeei, Shahla, et al.
Publicado: (2021)

Development of theophylline floating microballoons using cellulose acetate butyrate and/or Eudragit RL 100 polymers with different permeability characteristics
por: Jelvehgari, M., et al.
Publicado: (2010)

Comparison of physicomechanical properties of films prepared from organic solutions and aqueous dispersion of Eudragit RL
por: Sadeghi, F., et al.
Publicado: (2011)

Evaluation of the Mechanical Properties and Drug Permeability of Chitosan/Eudragit RL Composite Film
por: Kouchak, Maryam, et al.
Publicado: (2014)

Meltlets(®) of Soy Isoflavones: Process Optimization and the Effect of Extrusion Spheronization Process Parameters on Antioxidant Activity
por: Deshmukh, Ketkee, et al.
Publicado: (2013)

Uptake of Eudragit Retard L (Eudragit(®) RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats
por: Abdel-Wahhab, Mosaad A., et al.
Publicado: (2014)

Data on statistical experimental design to formulate amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis
por: Melo, Carolina M., et al.
Publicado: (2020)

Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarate
por: Soltani, Saieede, et al.
Publicado: (2016)

The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices
por: Kaffash, Ehsan, et al.
Publicado: (2021)

Modified extrusion-spheronization as a technique of microencapsulation for stabilization of choline bitartrate using hydrogenated soya bean oil
por: Gangurde, Avinash Bhaskar, et al.
Publicado: (2015)

Surface Deposition and Coalescence and Coacervation Phase Separation Methods: In Vitro Study and Compatibility Analysis of Eudragit RS30D, Eudragit RL30D, and Carbopol-PLA Loaded Metronidazole Microspheres
por: Dewan, Irin, et al.
Publicado: (2015)

Effects of spray drying conditions on the physicochemical properties of the Tramadol-Hcl microparticles containing Eudragit(®) RS and RL
por: Patel, A. S., et al.
Publicado: (2012)

Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles
por: Salatin, Sara, et al.
Publicado: (2017)

Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets: In-vitro and ex-vivo studies
por: Alagili, Modhi F., et al.
Publicado: (2023)

Chitosan-Montmorillonite Polymer Composites: Formulation and Evaluation of Sustained Release Tablets of Aceclofenac
por: Thakur, Garima, et al.
Publicado: (2015)

Preparation and pharmacokinetics in beagle dogs of ganershu sustained-release pellets
por: Pan, Jin-huo, et al.
Publicado: (2014)

Curcumin micelles entrapped in eudragit S-100 matrix: a synergistic strategy for enhanced oral delivery
por: Yusuf, Helmy, et al.
Publicado: (2021)

Preparation, Optimization and in vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100
por: Saharan, P., et al.
Publicado: (2019)

Preparation of Curcumin-Eudragit(®) E PO Solid Dispersions with Gradient Temperature through Hot-Melt Extrusion
por: Fan, Wenling, et al.
Publicado: (2021)

Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint
por: Kim, Sung Rae, et al.
Publicado: (2015)

Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit(®)RS100 polymer matrix-type drug in adhesive patches
por: Jafri, Ifrah, et al.
Publicado: (2019)

Development of Lyophilised Eudragit(®) Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
por: Lombardo, Rosamaria, et al.
Publicado: (2023)

Spheronized drug microcarrier system from canola straw lignin
por: Zhang, Liming, et al.
Publicado: (2023)

Formulation and evaluation of olanzapine matrix pellets for controlled release
por: Vishal Gupta, N., et al.
Publicado: (2011)

Core–Shell Eudragit S100 Nanofibers Prepared via Triaxial Electrospinning to Provide a Colon-Targeted Extended Drug Release
por: Ding, Yanfei, et al.
Publicado: (2020)

Preparation and Evaluation of Aceclofenac Topical Microemulsion
por: Ramesh Shah, Rohit, et al.
Publicado: (2010)

Formation and Investigation of Electrospun Eudragit E100/Oregano Mats
por: Baranauskaite, Juste, et al.
Publicado: (2019)

Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
por: Herdiana, Yedi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aarietbedagb3lhbv5rfqbh6lp